Non Alcoholic Steatohepatitis Nash Market Scope And Analysis

  • Report Code : TIPRE00009653
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Non-Alcoholic Steatohepatitis Market Report - Analysis 2031

Buy Now

Non-Alcoholic Steatohepatitis Market Report Non-Alcoholic Steatohepatitis Market Size and Share Non-Alcoholic Steatohepatitis Market Scope and Analysis

Non-Alcoholic Steatohepatitis Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.53 Billion
Market Size by 2031 US$ 77.42 Billion
Global CAGR (2023 - 2031) 47.10%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Vitamin E and Pioglitazone
  • Ocaliva
  • Elafibranor
  • Selonsertib & Cenicriviroc
By Application
  • Treatment and Diagnosis
By Sales Channel
  • Hospital Pharmacy
  • Online Provider
  • Retail Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Genfit SA
  • One Way Liver S L
  • BioPredictive S A S
  • Cadila Pharmaceuticals Ltd
  • Prometheus Laboratories
  • Siemens Healthineers AG
  • Intercept Pharmaceuticals Inc
  • Novartis AG
  • Galmed Pharmaceuticals
  • Laboratory Corporation of America Holdings
    		•